Orthofix Medical Inc OFIX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OFIX is a good fit for your portfolio.
News
-
Orthofix to Participate in Canaccord Genuity's 44th Annual Growth Conference
-
Orthofix Names Stephanie Walsh Chief Human Resources Officer
-
OFIX The Schall Law Firm is Investigating Claims Against Orthofix Medical Inc.
-
OFIX The Schall Law Firm is Investigating Claims Against Orthofix Medical Inc.
-
Orthofix Announces 510(k) Clearance and First Implant of Fitbone Transport and Lengthening System
-
Orthofix to Report Second Quarter 2024 Financial Results
-
Michael Finegan Named Chair of the Orthofix Board of Directors
-
Aviva McPherron Joins Orthofix as President of Global Operations and Quality
Trading Information
- Previous Close Price
- $16.51
- Day Range
- $16.21–16.92
- 52-Week Range
- $9.58–21.60
- Bid/Ask
- $15.58 / $17.10
- Market Cap
- $619.61 Mil
- Volume/Avg
- 242,940 / 303,505
Key Statistics
- Price/Earnings (Normalized)
- 732.72
- Price/Sales
- 0.81
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,634
- Website
- https://www.orthofix.com
Comparables
Valuation
|
Metric
|
OFIX
|
ZIMV
|
MMSI
|
|---|---|---|---|
Price/Earnings (Normalized) | 732.72 | 24.57 | 27.25 |
Price/Book Value | 1.08 | 1.52 | 4.01 |
Price/Sales | 0.81 | 1.06 | 3.90 |
Price/Cash Flow | 24.14 | 24.11 | 21.91 |
Price/Earnings
OFIX
ZIMV
MMSI
Financial Strength
|
Metric
|
OFIX
|
ZIMV
|
MMSI
|
|---|---|---|---|
Quick Ratio | 1.01 | 0.66 | 4.22 |
Current Ratio | 2.65 | 2.68 | 6.03 |
Interest Coverage | −9.38 | −1.06 | 6.17 |
Quick Ratio
OFIX
ZIMV
MMSI
Profitability
|
Metric
|
OFIX
|
ZIMV
|
MMSI
|
|---|---|---|---|
Return on Assets (Normalized) | −9.76% | −0.10% | 9.17% |
Return on Equity (Normalized) | −14.40% | −0.24% | 15.14% |
Return on Invested Capital (Normalized) | −11.08% | 0.96% | 10.93% |
Return on Assets
OFIX
ZIMV
MMSI
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Pqdrhrwn | Vbcwkn | $183.1 Bil | |||
| Stryker Corp
SYK
| Vpysckprf | Mjzs | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Xdjpfgbd | Wfmjlc | $110.1 Bil | |||
| Medtronic PLC
MDT
| Wzkbyqq | Zyypbp | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Twwgpmhhvt | Phprt | $37.6 Bil | |||
| DexCom Inc
DXCM
| Fsjhrrndh | Mww | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Pblztlr | Hbfwqx | $24.1 Bil | |||
| Steris PLC
STE
| Zfdwvbd | Vrldd | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Nvwmlbgl | Kspq | $22.9 Bil | |||
| Align Technology Inc
ALGN
| Xwrrjbr | Syyshf | $16.6 Bil |